Skip to main content

Find Clinical Trials

Home
Conditions
Allergic Conjunctivitis

Clinical trial condition

Allergic Conjunctivitis

Explore clinical trials studying Allergic Conjunctivitis. Study availability and eligibility vary by location and protocol.

112 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Allergic Conjunctivitis trial results

Completed

Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis.

NCT00769886

Conditions: Allergic Conjunctivitis, Conjunctival Diseases, Conjunctivitis, +5 more
Locations: Ophthalmic Research Consultants, Inc. North Andover, Massachusetts, United States

View Trial Details

Completed

A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis

NCT02578914

Conditions: Allergic Conjunctivitis, Conjunctival Diseases, Conjunctivitis, +13 more
Locations: Inflamax Research Inc. Mississauga, Ontario, Canada

View Trial Details

Completed

Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis

NCT00836485

Conditions: Allergic Conjunctivitis, Conjunctival Diseases, Conjunctivitis, +5 more
Locations: Ora Andover, Massachusetts, United States

View Trial Details

Completed

A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle

NCT03489941

Conditions: Allergic Conjunctivitis, Conjunctival Diseases, Conjunctivitis, +5 more
Locations: Total Eye Care, PA Memphis, Tennessee, United States

View Trial Details

Completed

PMCF Study to Evaluate Performance and Safety of "Xanoftal Next"

NCT05829499

Conditions: Allergic Conjunctivitis, Conjunctival Diseases, Conjunctivitis, +9 more
Locations: Azienda Ospedaliera Policlinico Mater Domini - Università Magna Grecia di Catanzaro Catanzaro, CZ, Italy

View Trial Details

Completed

PMCF Study to Evaluate Performance and Safety of "Optrex Double Action Soothing and Lubricating Drops"

NCT05824000

Conditions: Allergic Conjunctivitis, Conjunctival Diseases, Conjunctivitis, +9 more
Locations: Azienda Ospedaliera Policlinico Mater Domini - Università Magna Grecia di Catanzaro Catanzaro, CZ, Italy

View Trial Details

Completed

Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis

NCT02978183

Conditions: Allergic Conjunctivitis, Conjunctival Diseases, Conjunctivitis, +5 more
Locations: Andover, Massachusetts, United States

Memphis, Tennessee, United States

View Trial Details

Completed

A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® Model

NCT03231969

Conditions: Allergic Conjunctivitis, Conjunctival Diseases, Conjunctivitis, +5 more
Locations: Ora Clinical Research Center Andover, Massachusetts, United States

View Trial Details

Completed

Study to Assess the Safety, Tolerability and Efficacy of Bilastine Ophthalmic Solution 0.6% in Children

NCT04810390

Conditions: Allergic Conjunctivitis, Conjunctival Diseases, Conjunctivitis, +5 more
Locations: Hospital Universitario de Cruces Barakaldo, Bizkaia, Spain

Instituto Oftálmologico Quironsalud A Coruña A Coruña, Spain

Hospital Universitari German Trias i Pujol (HGTiP), Badalona, Spain

Hospital Universitari Dexeus Barcelona, Spain

View all 18 locations

View Trial Details

Completed

A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.

NCT03479307

Conditions: Allergic Conjunctivitis, Conjunctival Diseases, Conjunctivitis, +5 more
Locations: Cornea Consultants of AZ Phoenix, Arizona, United States

East West Eye Institute Torrance, California, United States

Andover Eye Associates Andover, Massachusetts, United States

Apex Eye Mason, Ohio, United States

View Trial Details